Source: Genomeweb

Cradle Genomics: Echelon Diagnostics, Cradle Genomics Ink Noninvasive Prenatal Diagnostics Partnership

The companies are working together to accelerate the development of Cradle's fetal cell isolation and analysis technology for noninvasive prenatal testing.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Tristan Orpin's photo - Co-Founder & CEO of Cradle Genomics

Co-Founder & CEO

Tristan Orpin

CEO Approval Rating

90/100

Read more